June 2016 FDA Recall Sirolimus by Dr. Reddy's Laboratories, Inc.
D-1063-2016 - Failed impurities/degradation
This Class III drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on June 3, 2016 for the product Sirolimus. The FDA reported the reason for recall as failed impurities/degradation. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1063-2016
Failed impurities/degradation: out of specification result for impurity secorapamycin.
06-03-2016
07-13-2016
9,330 bottles
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Dr. Reddy's Laboratories, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide
04-07-2017
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Sirolimus Tablets, 1 mg, 100-count bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Visakhapatnam - 5300046 India, NDC 55111-653-01
Batch or Lot Expiration Information
Lot# H400044, H400045 , Exp 07/16; H400048, Exp 08/16; H400055, Exp 10/16; H400070, H400071, H400073 and H400074, Exp 11/16
